Antonia Dimitrakopoulou-Strauss, M.D., Ph.D., (born 1963 in Athens, Greece) is a researcher, physician and professor of nuclear medicine at the University of Heidelberg. Currently she is deputy head of the Clinical Cooperation Unit Nuclear Medicine at the German Cancer Research Center (DKFZ) in Heidelberg.
She studied medicine at the Medical School of the National and Kapodistrian University of Athens. After completion of her studies, she joined the Dept. of Radiology of the German Cancer Research Center in 1988, where she completed the doctoral thesis in radiology in 1990. In 1998 she earned the qualification for nuclear medicine. After her habilitation in 2004 she became an Assistant Professor of Nuclear Medicine and in 2007 a Full Professor (APL professor) of the Univ. of Heidelberg.
The research focus of her is the use of positron emission tomography in oncological patients. The spectrum of her scientific work included many different tumor entities and different radiolabelled drugs. One of her major research topics is the individualization of chemo- and immunotherapy and the prognosis of therapeutic outcome in particular in oncological patients who receive new treatments protocols like immune checkpoint inhibitors, proteasome inhibitors, kinase inhibitors or novel antibodies.
Antonia Dimitrakopoulou-Strauss, M.D., Ph.D., (born 1963 in Athens, Greece) is a researcher, physician and professor of nuclear medicine at the University of Heidelberg. Currently she is deputy head of the Clinical Cooperation Unit Nuclear Medicine at the German Cancer Research Center (DKFZ) in Heidelberg.
She studied medicine at the Medical School of the National and Kapodistrian University of Athens. After completion of her studies, she joined the Dept. of Radiology of the German Cancer Research Center in 1988, where she completed the doctoral thesis in radiology in 1990. In 1998 she earned the qualification for nuclear medicine. After her habilitation in 2004 she became an Assistant Professor of Nuclear Medicine and in 2007 a Full Professor (APL professor) of the Univ. of Heidelberg.
The research focus of her is the use of positron emission tomography in oncological patients. The spectrum of her scientific work included many different tumor entities and different radiolabelled drugs. One of her major research topics is the individualization of chemo- and immunotherapy and the prognosis of therapeutic outcome in particular in oncological patients who receive new treatments protocols like immune checkpoint inhibitors, proteasome inhibitors, kinase inhibitors or novel antibodies.
Advance your academic career, collaborate globally, and expand your network—
join now
!
Well done!
